Heart allograft protection with low-dose carbon monoxide inhalation: Effects on inflammatory mediators and alloreactive T-cell responses

Transplantation

Volumn 81, Issue 2, 2006, Pages 220-230

  Nakao, Atsunori ^a   Toyokawa, Hideyoshi ^a   Abe, Masanori ^a   Kiyomoto, Tetsuma ^a   Nakahira, Kiichi ^a   Choi, Augustine M K ^a   Nalesnik, Michael A ^a   Thomson, Angus W ^a   Murase, Noriko ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Carbon monoxide; Chronic rejection; Heart transplantation; Heme oxygenase; Inflammation

Indexed keywords

CARBON MONOXIDE; CELL ADHESION MOLECULE; CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; TSUKUBAENOLIDE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; DNA; MESSENGER RNA;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERITIS; ARTICLE; CARDIAC GRAFT REJECTION; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; EXPOSURE; GRAFT SURVIVAL; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART TRANSPLANTATION; HETEROTOPIC TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LOW DRUG DOSE; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECIPIENT; REPERFUSION INJURY; T LYMPHOCYTE; TH1 CELL; UPREGULATION; ALLOTRANSPLANTATION; ANIMAL; BROWN NORWAY RAT; DRUG EFFECT; GENETICS; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; LEWIS RAT; METABOLISM; METHODOLOGY; NUCLEOTIDE SEQUENCE; PATHOLOGY; TIME;

ADMINISTRATION, INHALATION; ANIMALS; BASE SEQUENCE; CARBON MONOXIDE; CYTOKINES; DNA; GRAFT SURVIVAL; HEART TRANSPLANTATION; INFLAMMATION MEDIATORS; MALE; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, INBRED BN; RATS, INBRED LEW; RNA, MESSENGER; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33644850833     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000188637.80695.7f     Document Type: Article

References (57)

1. Libby P, Pober JS. Chronic rejection. Immunity 2001; 14 (4): 387.
2. Gourishankar S, Halloran PF. Late deterioration of organ transplants: a problem in injury and homeostasis. Curr Opin Immunol 2002; 14(5): 576.
3. Lunz JG, 3rd, Contrucci S, Ruppert K, et al. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. Am J Pathol 2001; 158(4): 1379.
4. el-Agroudy AE, Hassan NA, Bakr MA, et al. Effect of donor/recipient body weight mismatch on patient and graft outcome in living-donor kidney transplantation. Am J Nephrol 2003; 23(5): 294.
5. Liu S, Lutz J, Antus B, et al. Recipient age and weight affect chronic renal allograft rejection in rats. J Am Soc Nephrol 2001; 12(8): 1742.
6. Pratschke J, Paz D, Wilhelm MJ, et al. Donor hypertension increases graft immunogenicity and intensifies chronic changes in long-surviving renal allografts. Transplantation 2004; 77(1): 43.
7. Paul LC. Chronic renal transplant loss. Kidney Int 1995; 47(6): 1491.
8. Tilney NL, Guttmann RD. Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation 1997; 64(7): 945.
9. Hancock WW, Buelow R, Sayegh MH, Turka LA. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 1998; 4(12): 1392.
10. Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A 1968; 61(2): 748.
11. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003; 24(8): 449.
12. Katori M, Busuttil RW, Kupiec-Weglinski JW. Heme oxygenase-1 system in organ transplantation. Transplantation 2002; 74(7): 905.
13. Hangaishi M, Ishizaka N, Aizawa T, et al. Induction of heme oxygenase- 1 can act protectively against cardiac ischemia/reperfusion in vivo. Biochem Biophys Res Commun 2000; 279(2): 582.
14. Maines MD, Mayer RD, Ewing JF, McCoubrey WK, Jr. Induction of kidney heme oxygenase-1 (HSP32) mRNA and protein by ischemia/repertusion: possible role of heme as both promotor of tissue damage and regulator of HSP32. J Pharmacol Exp Ther 1993; 264(1): 457.
15. Amersi F, Buelow R, Kato H, et al. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 1999; 104(11): 1631.
16. Tullius SG, Nieminen-Kelha M, Buelow R, et al. Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation 2002; 74(5): 591.
17. Niimi M, Takashina M, Takami H, et al. Overexpression of heme oxygenase-1 protects allogeneic thyroid grafts from rejection in naive mice. Surgery 2000; 128(6): 910.
18. Soares MP, Brouard S, Smith RN, Bach FH. Heme oxygenase-1, a protective gene that prevents the rejection of transplanted organs. Immunol Rev 2001; 184: 275.
19. DeBruyne LA, Magee JC, Buelow R, Bromberg JS. Gene transfer of immunomodulatory peptides correlates with heme oxygenase-1 induction and enhanced allograft survival. Transplantation 2000; 69(1): 120.
20. Chauveau C, Bouchet D, Roussel JC, et al. Gene transfer of heme oxygenase- 1 and carbon monoxide delivery inhibit chronic rejection. Am J Transplant 2002; 2(7): 581.
21. Woo J, Iyer S, Mori N, Buelow R. Alleviation of graft-versus-host disease after conditioning with cobalt-protoporphyrin, an inducer of heme oxygenase-1. Transplantation 2000; 69(4): 623.
22. Nakao A, Moore BA, Murase N, et al. Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility. Gut 2003; 52(9): 1278.
23. Nakao A, Kimizuka K, Stolz DB, et al. Protective effect of carbon monoxide inhalation for cold-preserved small intestinal grafts. Surgery 2003; 134(2): 285.
24. Amersi F, Shen XD, Anselmo D, et al. Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology 2002; 35(4): 815.
25. Akamatsu Y, Haga M, Tyagi S, et al. Heme oxygenase-1-derived carbon monoxide protects hearts from transplant-associated ischemia reperfusion injury. FASEB J 2004; 18(6): 771.
26. Song R, Kubo M, Morse D, et al. Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am J Pathol 2003; 163(1): 231.
27. Sato K, Balla J, Otterbein L, et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 2001; 166(6): 4185.
28. Otterbein LE, Zuckerbraun BS, Haga M, et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003; 9(2): 183.
29. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57(2): 225.
30. Nakao A, Kimizuka K, Stolz DB, et al. Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am J Pathol 2003; 163(4): 1587.
31. Demetris AJ, Murase N, Ye Q, et al. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol 1997; 150(2): 563.
32. Murase N, Starzl TE, Tanabe M, et al. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation 1995; 60(2): 158.
33. Choi AM, Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 1996; 15(1): 9.
34. Otterbein LE, Mantell LL, Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol 1999; 276(4 Pt 1): L688.
35. Ke B, Buelow R, Shen XD, et al. Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-media ted apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Hum Gene Ther 2002; 13(10): 1189.
36. Tsui TY, Wu X, Lau CK, et al. Prevention of chronic deterioration of heart allograft by recombinant adeno-associated virus-mediated heme oxygenase-1 gene transfer. Circulation 2003; 107(20): 2623.
37. Braudeau C, Bouchet D, Tesson L, et al. Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther 2004; 11(8): 701.
38. Visner GA, Lu F, Zhou H, et al. Graft protective effects of heme oxygenase 1 in mouse tracheal transplant-related obliterative bronchiolitis. Transplantation 2003; 76(4): 650.
39. Araujo JA, Meng L, Tward AD, et al. Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse. J Immunol 2003; 171(3): 1572.
40. Soares MP, Lin Y, Anrather J, et al. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 1998; 4(9): 1073.
41. Neto JS, Nakao A, Kimizuka K, et al. Protection of Transplant-Induced Renal Ischemia/Reperfusion Injury with Carbon Monoxide. Am J Physiol Renal Physiol 2004; 287: F979.
42. Otterbein LE, Bach FH, Alam J, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000; 6(4): 422.
43. Thiemermann C, Inhaled Co deadly gas or novel therapeutic? Nat Med 2001; 7(5): 534.
44. Ryter SW, Morse D, Choi AM. Carbon monoxide: to boldly go where NO has gone before. Sci STKE 2004; (230):RE6.
45. Tullius SG, Heemann U, Hancock WW, et al. Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg 1994; 220(4): 425.
46. Herrero-Fresneda I, Torras J, Cruzado JM, et al. Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy? Am J Pathol 2003; 162(1): 127.
47. Pae HO, Oh GS, Choi BM, et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 2004; 172(8): 4744.
48. Song R, Mahidhara RS, Zhou Z, et al. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J Immunol 2004; 172(2): 1220.
49. Kapturczak MH, Wasserfall C, Brusko T, et al. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am J Pathol 2004; 165(3): 1045.
50. Poss KD, Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A 1997; 94(20): 10919.
51. Yachie A, Niida Y, Wada T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999; 103(1): 129.
52. Monta T, Mitsialis SA, Koike H, et al. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 1997; 272(52): 32804.
53. Verma A, Hirsch DJ, Glatt CE, et al. Carbon monoxide: a putative neural messenger. Science 1993; 259(5093): 381.
54. Blackmore DJ. The determination of carbon monoxide in blood and tissue. Analyst 1970; 95(130): 439.
55. Sokal JA, Majka J, Palus J. The content of carbon monoxide in the tissues of rats intoxicated with carbon monoxide in various conditions of acute exposure. Arch Toxicol 1984; 56(2): 106.
56. Marks GS, Vreman HJ, McLaughlin BE, et al. Measurement of endogenous carbon monoxide formation in biological systems. Antioxid Redox Signal 2002;4(2):271.
57. Mahoney JJ, Vreman HJ, Stevenson DK, Van Kessel AL. Measurement of carboxyhemoglobin and total hemoglobin by five specialized spectrophotometers (CO-oximeters) in comparison with reference methods. Clin Chem 1993; 39(8): 1693.